High-throughput approaches to the quantitative analysis of ketoconazole, a potent inhibitor of cytochrome P450 3A4, in human plasma

被引：0
|
作者：
Ramos, L. [1 ]
Brignol, N. [1 ]
Bakhtiar, R. [1 ,2 ]
Ray, T. [1 ]
Mc Mahon, L.M. [1 ]
Tse, F.L.S. [1 ]
机构：
[1] Department of Drug Metabolism and Pharmacokinetics, Novartis Institute for Biomedical Research, East Hanover, NJ 07936, United States
[2] Novartis Pharmaceuticals Corporation, 59 Route 10, East Hanover, NJ 07936, United States
来源：
| 2000年 / John Wiley and Sons Ltd卷 / 14期
关键词：
Antimycotic agent - Cytochrome P450-3A4 - High-throughput approaches - Human plasmas - Imidazol - Isoforms - Orally active - Potent inhibitor - Sample preparation - Specific inhibitors;
D O I：
10.1002/1097-0231(20001215)14:233.0.CO;2-V
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Screening of cytochrome P450 3A4 inhibitors via in silico and in vitro approaches
    Pang, Xiaocong
    Zhang, Baoyue
    Mu, Guangyan
    Xia, Jie
    Xiang, Qian
    Zhao, Xia
    Liu, Ailin
    Du, Guanhua
    Cui, Yimin
    RSC ADVANCES, 2018, 8 (61) : 34783 - 34792
  • [32] Effect of Ticagrelor, a Cytochrome P450 3A4 Inhibitor, on the Pharmacokinetics of Tadalafil in Rats
    Na, Young-Guk
    Byeon, Jin-Ju
    Huh, Hyun Wook
    Kim, Min-Ki
    Shin, Young G.
    Lee, Hong-Ki
    Cho, Cheong-Weon
    PHARMACEUTICS, 2019, 11 (07)
  • [33] Chromatographic assays of drug oxidation by human cytochrome P450 3A4
    Sohl, Christal D.
    Cheng, Qian
    Guengerich, F. Peter
    NATURE PROTOCOLS, 2009, 4 (09) : 1252 - 1257
  • [34] The one-electron autoxidation of human cytochrome p450 3A4
    Denisov, Ilia G.
    Grinkova, Yelena V.
    McLean, Mark A.
    Sligar, Stephen G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (37) : 26865 - 26873
  • [35] Kohonen maps for prediction of binding to human cytochrome P450 3A4
    Balakin, KV
    Ekins, S
    Bugrim, A
    Ivanenkov, YA
    Korolev, D
    Nikolsky, YV
    Skorenko, AV
    Ivashchenko, AA
    Savchuk, NP
    Nikolskaya, T
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (10) : 1183 - 1189
  • [36] Chromatographic assays of drug oxidation by human cytochrome P450 3A4
    Christal D Sohl
    Qian Cheng
    F Peter Guengerich
    Nature Protocols, 2009, 4 : 1252 - 1257
  • [37] Role of human cytochrome p450 3A4 in metabolism of medroxyprogesterone acetate
    Kobayashi, K
    Mimura, N
    Fujii, H
    Minami, H
    Sasaki, Y
    Shimada, N
    Chiba, K
    CLINICAL CANCER RESEARCH, 2000, 6 (08) : 3297 - 3303
  • [38] Potent and selective inhibition of human cytochrome P450 3A4 by seco-pancratistatin structural analogs
    McNulty, James
    Nair, Jerald J.
    Singh, Mohini
    Crankshaw, Denis J.
    Holloway, Alison C.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (07) : 2335 - 2339
  • [39] Expression of human cytochrome p450 3A4 gene in Schizosaccharomyces pombe
    Palabiyik, Bedia
    Karaer, Semian
    Arda, Nazli
    Toker, Sidika Erturk
    Temizkan, Guler
    Kelly, Steven
    Sarikaya, Aysegul Topal
    BIOLOGIA, 2008, 63 (03) : 450 - 454
  • [40] Interaction of methadone with substrates of human hepatic cytochrome P450 3A4
    Iribarne, C
    Dreano, Y
    Bardou, LG
    Menez, JF
    Berthou, F
    TOXICOLOGY, 1997, 117 (01) : 13 - 23
12345